Literature DB >> 31508867

The relationship between systolic pulmonary arterial pressure and Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with newly diagnosed chronic obstructive pulmonary disease.

Ayhan Cosgun1, Huseyin Oren2, Mustafa Hamidullah Turkkani3.   

Abstract

INTRODUCTION: The risk of sudden cardiac death (SCD) and arrhythmias has been shown to be common in chronic obstructive pulmonary disease (COPD) subjects. We aimed to evaluate the markers of arrhythmia such as QT, QTc (corrected QT), Tp-e, and cTp-e (corrected Tp-e) intervals, Tp-e/QT ratio, and Tp-e/QTc ratio in newly diagnosed COPD subjects in both right and left precordial leads.
MATERIALS AND METHODS: The study group consisted of 74 subjects with obstructive respiratory function tests (RFTs). The control group consisted of 78 subjects who had nonobstructive RFTs. RFTs, electrocardiograms (ECG), and transthoracic echocardiograms (TTE) were performed, and QTR (QT interval in right precordial leads), QTL (QT interval in left precordial leads), Tp-eR (Tp-e interval in right precordial leads), and Tp-eL (Tp-e interval in left precordial leads) intervals; systolic pulmonary arterial pressure (sPAP); forced expiratory volume in one second (FEV1 )/forced vital capacity (FVC); and peripheral oxygen saturation(POS) values were measured.
RESULTS: Tp-eR interval 85.82 ± 5.34 millisecond (ms) versus 62.87 ± 3.55 ms (t = 31.29/p < .00001), cTp-eR interval 97.51 ± 7.18 ms versus 71.07 ± 4.58 ms (t = 27.20/p < .00001), Tp-eR/QTR ratio 0.234 ± 0.02 versus 0.164 ± 0.01 (t = 2.2/p = .014), and Tp-eR/QTcR ratio 0.201 ± 0.01 versus 0.141 ± 0.01 (t = 1.92/p = .028) were statistically significantly higher in COPD subjects. There was a strong negative correlation between RFT and sPAP (sPAP, 29.93 ± 5.1 mm Hg; and FEV1 /FVC, 63.78 ± 3.33%, r = -.85/p < .00001). There was a moderate positive correlation between sPAP and Tp-eR.
CONCLUSION: We found Tp-e and cTp-e intervals, Tp-e/QT ratio, and Tp-e/QTc ratio were significantly higher in the COPD patients than in the control group. In addition, in the COPD group, heart rate variability (HRV) parameters were significantly lower on ECG.
© 2019 Wiley Periodicals, LLC.

Entities:  

Keywords:  Tp-e interval; Tp-e/QT ratio; Tp-e/QTc ratio; chronic obstructive pulmonary disease; respiratory function test; systolic pulmonary arterial pressure

Mesh:

Year:  2019        PMID: 31508867      PMCID: PMC7358838          DOI: 10.1111/anec.12691

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  40 in total

1.  Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients.

Authors:  Paul E Valensi; Nicolas B Johnson; Pierre Maison-Blanche; Fabrice Extramania; Gilbert Motte; Philippe Coumel
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

2.  A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell.

Authors:  S Sicouri; C Antzelevitch
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

3.  Evaluation of Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in aortic valve stenosis before and after transcatheter aortic valve implantation.

Authors:  Serkan Kahraman; Ali Dogan; Ali Kemal Kalkan; Arda Guler; Mesut Pak; Emre Yilmaz; Ismail Gurbak; Cafer Panc; Ali Riza Demir; Aydin Rodi Tosu; Omer Celik; Fatih Uzun; Nuri Kurtoglu; Mehmet Erturk
Journal:  J Electrocardiol       Date:  2018-08-10       Impact factor: 1.438

4.  Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Arnoldus J R van Gestel; Joerg Steier
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

5.  Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease.

Authors:  Roberto Zulli; Paolo Donati; Franco Nicosia; Massimiliano De Vecchi; Claudio Tantucci; Giuseppe Romanelli; Vittorio Grassi
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 6.  QT dispersion: problems of methodology and clinical significance.

Authors:  D J Statters; M Malik; D E Ward; A J Camm
Journal:  J Cardiovasc Electrophysiol       Date:  1994-08

Review 7.  Chronic obstructive pulmonary disease and sudden cardiac death: A systematic review.

Authors:  Marten E van den Berg; Bruno H Stricker; Guy G Brusselle; Lies Lahousse
Journal:  Trends Cardiovasc Med       Date:  2016-04-09       Impact factor: 6.677

Review 8.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

9.  Tp-e Interval, Tp-e/QTc Ratio, and Fragmented QRS Are Correlated with the Severity of Liver Cirrhosis.

Authors:  Mehmet Kadri Akboga; Mahmut Yuksel; Kevser Gulcihan Balci; Mustafa Kaplan; Serkan Cay; Volkan Gokbulut; Cagri Yayla; Ahmet Goktug Ertem; Meral Akdogan Ayhan; Serkan Topaloglu; Dursun Aras
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-04-07       Impact factor: 1.468

10.  Tp-e interval and Tp-e/QT ratio in patients with Human Immunodeficiency Virus.

Authors:  Sefa Ünal; Çağrı Yayla; Burak Açar; Ahmet G Ertem; Mehmet K Akboğa; Serkan Gökaslan; Mehmet A Erdöl; Meliha Ç Sönmezer; Esra Kaya Kiliç; Çiğdem Ataman Hatipoğlu; Necla Tulek; Fatma S Erdinç; Sinan Aydoğdu; Ahmet Temizhan
Journal:  J Infect Public Health       Date:  2017-03-09       Impact factor: 3.718

View more
  2 in total

1.  The relationship between systolic pulmonary arterial pressure and Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with newly diagnosed chronic obstructive pulmonary disease.

Authors:  Ayhan Cosgun; Huseyin Oren; Mustafa Hamidullah Turkkani
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-11       Impact factor: 1.468

2.  Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study.

Authors:  Chun-Chao Chen; Cheng-Hsin Lin; Wen-Rui Hao; Chun-Chih Chiu; Yu-Ann Fang; Ju-Chi Liu; Li-Chin Sung
Journal:  NPJ Prim Care Respir Med       Date:  2021-02-12       Impact factor: 2.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.